mobile menu
business
COMPANY BENCHMARKING • UNITED STATES

Prime Therapeutics Llc - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Prime Therapeutics Llc stacks up to the competition and put relevant competitor and industry information at your fingertips.


Prime Therapeutics Llc - Overview

Description
Prime Therapeutics Llc is a private company headquartered in Minnesota with an estimated 3,800 employees. In the US, the company has a notable market share in at least one industry: Health & Medical Insurance, where they account for an estimated 1.7% of total industry revenue and are considered a Laggard because they display lower market share alongside slower profit and revenue growth than their peers.
Company Details

Registered Name: Prime Therapeutics Llc

Company Type: Other

Headquarters: 2900 Ames Crossing Rd Eagan MN 55121

Website: https://www.primetherapeutics.com/

Employees: 3800

Prime Therapeutics Llc - Operating Industries and Main Competitors

error_outline To view all of Prime Therapeutics Llc's operating industries and competitors, see purchase options.

Prime Therapeutics Llc - Products and Services

  • Health & Medical Insurance in the US

  • Of the 7 core revenue-generating products and services in the Health & Medical Insurance in the US industry, Prime Therapeutics Llc offers:
    • Pharmacy benefit management (PBM)
error_outline To view Prime Therapeutics Llc's full products and services, see purchase options.

Prime Therapeutics Llc - Analyst Insights

Prime Therapeutics unveils its first diversity report

On February 25, 2022, Prime Therapeutics LLC (Prime) released its inaugural diversity, equity and inclusion (DEI) transparency report. The report highlights the goals of Prime's Diversity & Inclusion Council, including adopting a "radical welcome-ness" policy that aims to provide equal employment opportunities for individuals regardless of ethnicity, race, sexual orientation, or background. The report comes as Prime earned a perfect score on Human Rights Campaign Foundation's 2022 Corporate Equality Index.

New Activity|ESG


In response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.

Lorem Ipsum text header Report Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

error_outline To view all analyst insights on Prime Therapeutics Llc, see purchase options.

Prime Therapeutics Llc - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Prime Therapeutics Llc's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Health & Medical Insurance in the US industry.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Prime Therapeutics Llc's full SWOT analysis, see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Prime Therapeutics Llc includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal